ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
sailnyssa
|
1.0K |
492K |
13 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
1.0K
|
492K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
sailnyssa
|
1.0K |
492K |
25 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
1.0K
|
492K
|
25
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
14 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
23K
|
13M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 3 Articles on RYONCIL GvHD Trial Results Published in BBMT
|
|
sailnyssa
|
127 |
71K |
9 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
127
|
71K
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
3 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
2 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
9 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
4 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
25 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
23K
|
13M
|
25
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
22 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
23K
|
13M
|
22
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
10 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
10 |
16/05/20 |
16/05/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
sailnyssa
|
17K |
6.8M |
7 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
17K
|
6.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
sailnyssa
|
933 |
436K |
4 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
933
|
436K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
sailnyssa
|
933 |
436K |
4 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
933
|
436K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
sailnyssa
|
933 |
436K |
26 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
933
|
436K
|
26
|
|
ASX - By Stock
|
MYR |
Re:
Ann: COVID-19 Business Update
|
|
sailnyssa
|
157 |
69K |
4 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
157
|
69K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
sailnyssa
|
518 |
265K |
17 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
518
|
265K
|
17
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
13 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
23K
|
13M
|
13
|
|
ASX - By Stock
|
SPL |
Re:
An unfocused CEO
|
|
sailnyssa
|
26 |
8.2K |
7 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
26
|
8.2K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
5 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
7 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Confirmation Bias
|
|
sailnyssa
|
152 |
52K |
3 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
152
|
52K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
sailnyssa
|
203 |
94K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
203
|
94K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
sailnyssa
|
203 |
94K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
203
|
94K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
sailnyssa
|
203 |
94K |
5 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
203
|
94K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
sailnyssa
|
203 |
94K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
203
|
94K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
sailnyssa
|
203 |
94K |
9 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
203
|
94K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Valuation Musings
|
|
sailnyssa
|
64 |
38K |
1 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
64
|
38K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Valuation Musings
|
|
sailnyssa
|
64 |
38K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
64
|
38K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
sailnyssa
|
3.1K |
1.4M |
6 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
sailnyssa
|
847 |
336K |
1 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
847
|
336K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
sailnyssa
|
847 |
336K |
1 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
847
|
336K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Hostile takeover
|
|
sailnyssa
|
8 |
3.0K |
1 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
8
|
3.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Hostile takeover
|
|
sailnyssa
|
8 |
3.0K |
3 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
8
|
3.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Hostile takeover
|
|
sailnyssa
|
8 |
3.0K |
5 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
8
|
3.0K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
1 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
0 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
12 |
26/04/20 |
26/04/20 |
ASX - By Stock
|
23K
|
13M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Inflammatory Lung Disease Outcomes For Presentation at ISCT
|
|
sailnyssa
|
75 |
35K |
5 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
75
|
35K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Inflammatory Lung Disease Outcomes For Presentation at ISCT
|
|
sailnyssa
|
75 |
35K |
0 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
75
|
35K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast owns the patents . The science is now proven .
|
|
sailnyssa
|
47 |
23K |
1 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
47
|
23K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
4 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
5 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
9 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
11 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
12 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
23K
|
13M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
0 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
6 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
sailnyssa
|
23K |
13M |
7 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|